MDMA therapy for PTSD inpatients
Part of Mental health clinical trials.
This trial tests whether high-dose MDMA, given during intensive inpatient therapy, can help people with PTSD that hasn't improved with other treatments. It takes place at a specialized trauma center and involves several therapy sessions with the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must have been diagnosed with PTSD that hasn't gotten better with other treatments
- You must be a current patient at ARQ Centre'45 and speak Dutch
- You must have a support person who can be contacted if needed
- You must be able to swallow pills and have a body weight of at least 48 kg (about 106 pounds)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a psychedelic drug called psilocybin, given alongside talking therapy, can help veterans with long-lasting PTSD feel better. It may offer a new path for people whose symptoms haven't improved with other treatments.
This study tests whether MDMA combined with talk therapy can help young adults who have PTSD from childhood trauma. It involves several therapy sessions where you take MDMA in a clinical setting to help process the trauma.
This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.
This study tests whether MDMA (a drug that can help people feel safe and open during therapy) combined with talk therapy can reduce PTSD symptoms in active-duty service members, National Guard, and Reserve members. If you are struggling with PTSD that has lasted at least 6 months, this trial may offer a new treatment option.
This trial tests whether MDMA (the drug in ecstasy) combined with a type of talk therapy called massed exposure therapy can help treat PTSD. It may be an option if standard treatments haven't worked well enough.
This Phase 2 study tests whether MDMA combined with therapy that uses exposure (gradual confronting of trauma memories) can reduce PTSD symptoms. It may help people who meet PTSD criteria, can follow strict safety rules, and can complete medicine-session monitoring.
Hear when a new Posttraumatic Stress Disorder (PTSD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.